Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Illumina, Inc.    ILMN

ILLUMINA, INC.

(ILMN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/11/2021 01/12/2021 01/13/2021 01/14/2021 01/15/2021 Date
372.48(c) 361.28(c) 362(c) 371.04(c) 376.35(c) Last
1 933 712 1 270 456 1 430 222 860 422 1 865 870 Volume
-1.88% -3.01% +0.20% +2.50% +1.43% Change
More quotes
Financials (USD)
Sales 2020 3 226 M - -
Net income 2020 551 M - -
Net cash position 2020 2 230 M - -
P/E ratio 2020 101x
Yield 2020 -
Sales 2021 3 912 M - -
Net income 2021 921 M - -
Net cash position 2021 1 202 M - -
P/E ratio 2021 61,2x
Yield 2021 -
Capitalization 54 947 M 54 947 M -
EV / Sales 2020 16,3x
EV / Sales 2021 13,7x
Nbr of Employees 7 700
Free-Float 75,1%
More Financials
Company
Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and biotechnology companies. Net sales break down by source of income as follows: - product sales (82.7%): tools and... 
More about the company
Notations Surperformance© of Illumina, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about ILLUMINA, INC.
01/14Qiagen warns against using standard tests to track coronavirus variants
RE
01/12ILLUMINA, INC. : Results of Operations and Financial Condition, Financial Statem..
AQ
01/11ILLUMINA : New Bioinformatics Solution Powers Multi-Omics Discovery at Massive S..
BU
01/11ILLUMINA : Announces New and Expanded Oncology Partnerships with Bristol Myers S..
BU
01/11Grail in Minimum Residual Disease Collaborations With Amgen, AstraZeneca, Bri..
DJ
01/07ILLUMINA : Insider Sales at Illumina (ILMN) are Significant and Extend the Selli..
MT
01/06INSIDER TRENDS : Insider Adds to 90-Day Selling Trend at Illumina
MT
01/06INSIDER TRENDS : Selling By Insiders Lingers at Illumina
MT
01/05ILLUMINA : and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Varia..
BU
2020ILLUMINA : Piper Sandler Upgrades Illumina to Overweight From Neutral, Adjusts P..
MT
2020ILLUMINA : to Webcast Upcoming Investor Conference Presentations
BU
2020ILLUMINA : Insiders Make Significant Stock Sales in Illumina (ILMN) Shares Exten..
MT
2020ILLUMINA : BTIG Upgrades Illumina to Buy From Neutral; Price Target is $410
MT
2020INSIDER TRENDS : Insider Prolongs Selling Trend at Illumina
MT
2020ILLUMINA : Continued Level of Significant Insider Selling at Illumina (ILMN)
MT
More news
News in other languages on ILLUMINA, INC.
2020ILLUMINA, INC. : Veröffentlichung des Quartalsergebnisses
2020ILLUMINA, INC. : publication des résultats trimestriels
2020ILLUMINA : bietet für Krebstest-Hersteller Grail acht Milliarden Dollar
2020WALL STREET STOCK EXCHANGE : Les valeurs à suivre à Wall Street
2020Illumina will Krebsdiagnose-Spezialisten Grail kaufen
More news
Analyst Recommendations on ILLUMINA, INC.
More recommendations
Chart ILLUMINA, INC.
Duration : Period :
Illumina, Inc. Technical Analysis Chart | ILMN | US4523271090 | MarketScreener
Technical analysis trends ILLUMINA, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 17
Average target price 322,31 $
Last Close Price 376,35 $
Spread / Highest target 10,3%
Spread / Average Target -14,4%
Spread / Lowest Target -33,6%
EPS Revisions
Managers and Directors
NameTitle
Francis A. deSouza President, Chief Executive Officer & Director
Jay T. Flatley Executive Chairman
Robert P. Ragusa Senior Vice President-Global Quality & Operations
Sam A. Samad Chief Financial Officer & Senior Vice President
Phillip G. Febbo Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ILLUMINA, INC.1.72%54 947
THERMO FISHER SCIENTIFIC6.68%199 412
DANAHER CORPORATION6.58%168 182
INTUITIVE SURGICAL, INC.-4.85%91 508
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.3.75%82 922
SIEMENS HEALTHINEERS AG3.86%56 444